SYNCELL is a startup company revolutionizing cell biology by introducing the groundbreaking "Microscoop", the first system in the world allowing you to pick up any part you are interested in within a cell under a microscope, a total game changer for protein identification. SYNCELL Microscoop technology enables novel biomarker identification, studies of molecular mechanisms of diseases, and drug target deconvolution. Microscoop has been chosen to the second round of this year's The Scientist Top 10 Innovations Competition, a prestigious recognition in the equipment industry. Integrating microscopy, deep learning, mechatronics, optics, photochemistry, biochemistry, and mass spectrometry with 5 years of development, Microscoop is expected to be indispensable for next-generation biological research, pushing our current limit of whole cell DNA/RNA studies to a new horizon of highly-anticipated whole cell protein studies. The prototype of Microscoop was ready in April 2020, and we aim to launch the product in the middle of 2021.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Taiwan
Year Founded:
2020
Main Therapeutic Focus:
Medical Devices
Lead Product in Development:
Microscoop
Development Phase of Primary Product:
Other/Not Applicable
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
